Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Mayo Clinic Cancer Center Clinical Trials Resources presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, calls or treatment with a genuine mD. We aren't mDs. Always consult your dr. on Mayo Clinic Cancer Center clinical studies. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Mayo Clinic Cancer Center Clinical research trials and Mayo Clinic Cancer Center medical trials occur in hundreds of cities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually assess the effectiveness of new drugs. The propose of the studies / projects is to resolve certain human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector corporations like Mayo Clinic Cancer Center to detect remedies for all kinds of conditions. Mayo Clinic Cancer Center Clinical Trials and other clinical trials permit volunteers to obtain health treatment options before they are available to the general public. Some times the participants undergo professional assistance for without cost, and every now and again they are compensated for their time. Occasionally there is a cost for a Mayo Clinic Cancer Center clinical trial. Subjects frequently receive the most effective healthcare possible for their condition. Dangers are a reality, nonetheless, and might include additional or frequent doctor calls, medical risks (possibly life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.

Home > "M" Clinical Trials Sponsors > Mayo Clinic Cancer Center Clinical Trials

Mayo Clinic Cancer Center Clinical Trials



17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Combination Chemotherapy in Treating Patients With Advanced Cancer
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Erlotinib and Irinotecan in Treating Patients With Advanced Solid Tumors
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin’s Lymphoma
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for High-Risk Stage II or Stage III Prostate Cancer
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

PS-341 in Treating Patients With Advanced Cancer
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Screening Tests in Detecting Colorectal Cancer
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Tipifarnib in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center

Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Condition: mayo_clinic_cancer_center_clinical_trials.html
Mayo Clinic Cancer Center



Mayo Clinic Cancer Center Clinical Trials
Modify your Search

Other "M" Clinical Trials Sponsors:

M.d. Anderson Cancer Center
Massachusetts General Hospital
Massey Cancer Center
Maxim Pharmaceuticals
Mayo Clinic
Mayo Clinic Cancer Center
Mcneil Consumer & Specialty Pharmaceuticals
Medarex
Medical College Of Pennsylvania Hospital
Medical College Of Wisconsin
Medical Research Council
Medical Research Laboratories International
Medigene
Medimmune, Inc.
Medizinische Hochschule Hannover
Medsearch
Medstone International
Memorial Sloan-Kettering Cancer Center
Merck
Merck Research Laboratories
Merieux Institute
Metabasis Therapeutics
Metaphore Pharmaceuticals
Microgenesys
Micrologix Biotech
Mid-Atlantic Oncology Program
Midamerica Neuroscience Institute
Midwestern Regional Medical Center
Milkhaus Laboratory
Millennium Pharmaceuticals
Millennix
Milton S. Hershey Medical Center
Mitsubishi Pharma Corporation
Mount Sinai Medical Center
Mount Vernon Hospital
Mucos Pharma Gmbh And Co
Mylan Laboratories
Myogen
Myriad Pharmaceuticals


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103